Vivo Bio Tech Ltd Stock Analysis

BSE: 511509 | NSE: | Miscellaneous | Small Cap

BSE Share Price Jan 20, 18:01
69.55 -0.05 (-0.07%)

DeciZen - Make an Informed Decision on Vivo Bio Tech

M-Cap below 100cr DeciZen not available

FAQ's

1. Is Vivo Bio Tech Ltd a good quality company?

Data is not available for this company.

2. Is Vivo Bio Tech Ltd undervalued or overvalued?

The key valuation ratios of Vivo Bio Tech Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Vivo Bio Tech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Vivo Bio Tech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vivo Bio Tech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 11.3%4.7%4.2%5.5%6%10.2%11.4%8.9%12.8%13%-
Value Creation Index -0.2-0.7-0.7-0.6-0.6-0.3-0.2-0.4-0.1-0.1-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 12.514.416.117.828.634.14755.855.451.851
YoY Gr. Rt. %-15.1%12.3%10.3%60.7%19.4%37.7%18.8%-0.9%-6.5%-
Adj EPS 0.80.40.30.512.73.21.93.54.22.9
YoY Gr. Rt. %--44.7%-26.2%61.3%96%173.5%19%-41.4%85.6%21.6%-
BVPS (₹) 5.28.89.19.810.713.517.521.825.630.632.6
Adj Net Profit 0.70.40.30.50.92.53.12.34.55.74
Cash Flow from Ops. 4.72.12.82.18.7-5.711.1-0.87.714.1-
Debt/CF from Ops. 4.91.72.42.71.9-4.82.3-27.52.92-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 17.1%12.6%3.3%-6.5%
Adj EPS 21%33.9%9.8%21.6%
BVPS 21.723.320.619.6
Share Price - -6.7% -0.3% 32%

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % 15.563.55.39.522.119.79.914.8159.1
Op. Profit Mgn % 42.516.510.815.81322.423.217.222.634.433.7
Net Profit Mgn % 5.72.71.82.63.27.36.74.18.1117.9
Debt to Equity 4.70.40.80.61.72.21.50.80.70.70.3
Working Cap Days 204193179199138155165158170191294
Cash Conv. Cycle -401-240-228-41-45-11375381118118

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.70

Return on Equity has declined versus last 3 years average to 9.00%

Sales growth has been subdued in last 3 years 3.28%

Net Profit has been subdued in last 3 years 9.78%

Sales growth is not so good in last 4 quarters at 1.88%

Latest Financials - Vivo Bio Tech Ltd.

Standalone Consolidated
TTM EPS (₹) 2.9 2.8
TTM Sales (₹ Cr.) 51.1 51.1
BVPS (₹.) 32.6 32.6
Reserves (₹ Cr.) 32 32
P/BV 2.13 2.13
PE 24.33 24.45
From the Market
52 Week Low / High (₹) 47.00 / 115.10
All Time Low / High (₹) 1.10 / 115.10
Market Cap (₹ Cr.) 98.8
Equity (₹ Cr.) 14.2
Face Value (₹) 10
Industry PE 62.8

Management X-Ray of Vivo Bio Tech :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Vivo Bio Tech Ltd

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

It is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of custom research, In-vitro and In-vivo toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities.

The Custom Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.

In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists.

Vivo Bio Tech has obtained permission from the Govt. of India for developing Biotech Sector Specific 'Special Economic Zone' at its site (39 acres) in Pregnapur, Gajwel Mandal, Medak District, Andhra Pradesh.The Vivo Bio Tech SEZ is located adjacent to Karimnagar highway road (approx 16 km from ICICI Knowledge Park and SP Biotech Park). The site is approximately 53km from Secunderabad Railway Station and around 90km from the new airport (Shamshabad).

Read More Read Less